• Priyam Singh

India's biotech policy is constantly changing, but its basic principles for creating a vibrant industry have been developed. The Indian biotechnology industry was slow to launch, but has gained traction and the software sector is now booming. The current market share in the global market is only 1.1 percent, but to become a leading player in the global biotech market, the Indian industry has the requisite ingredients. The biotech sector in India is one of the top five in the Asia Pacific region today. India not only shows tremendous potential as a destination for new-generation pharmaceuticals, biotech products and diagnostics, but is also becoming an important outsourcing center for clinical features and contract research. Though India has yet to launch a new biotechnology product, it has strong support for science and the potential to create $5 billion in revenue and a million jobs by 2010. The Indian biotech field has witnessed a number of dispersed and intermittent initiatives on the academic and industrial front over the last two decades. The rapid development of technology has opened up a wide variety of options for us. Some big advances have once been seen in engineering, which was limited to machines and other associated abiotic segments, and now we can alter or genetically manipulate living organisms.

Biotech, Intellectual Property, Organism, Outsourcing, Product.

"Intellectual Property Rights and Biotechnology", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 4, page no.331-334, April-2019, Available :http://www.jetir.org/papers/JETIREQ06076.pdf

"Intellectual Property Rights and Biotechnology", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 4, page no. pp331-334, April-2019, Available at : http://www.jetir.org/papers/JETIREQ06076.pdf